| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.34 | 0.03 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |